ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,793
Diagnostic referrals
1,090
Outstanding pathways
365

Screening pathway

  1. Screening5,793Encounters
  2. Positive finding2,069Documented findings
  3. Referral1,090Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 80.

Participant insight

Expanded synthetic participant 0761 · EXP-0761Synthetic · Site B

Full participant history through 2028-03-06, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-24
  5. · Surveillance · HPV DNA · Surveillance · HPV positive with negative triage
  6. · Surveillance result · HPV DNA · HPV not detected · Adequate

Referral-time risk

No matching referral was available at this observation date.

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1001 · Expanded synthetic participant 1001Site E — Resource-Constrained Navigation Programme
EXP-1002 · Expanded synthetic participant 1002Site A — Urban Referral Hub
EXP-1003 · Expanded synthetic participant 1003Site C — Rural Outreach Programme
EXP-1005 · Expanded synthetic participant 1005Site D — Community Engagement Programme
EXP-1006 · Expanded synthetic participant 1006Site E — Resource-Constrained Navigation Programme
EXP-1009 · Expanded synthetic participant 1009Site E — Resource-Constrained Navigation Programme
EXP-1010 · Expanded synthetic participant 1010Site A — Urban Referral Hub
EXP-1012 · Expanded synthetic participant 1012Site D — Community Engagement Programme
EXP-1013 · Expanded synthetic participant 1013Site D — Community Engagement Programme
EXP-1014 · Expanded synthetic participant 1014Site B — Peri-Urban Access Programme
EXP-1015 · Expanded synthetic participant 1015Site A — Urban Referral Hub
EXP-1016 · Expanded synthetic participant 1016Site B — Peri-Urban Access Programme
EXP-1017 · Expanded synthetic participant 1017Site D — Community Engagement Programme
EXP-1018 · Expanded synthetic participant 1018Site D — Community Engagement Programme
EXP-1019 · Expanded synthetic participant 1019Site D — Community Engagement Programme
EXP-1020 · Expanded synthetic participant 1020Site E — Resource-Constrained Navigation Programme
EXP-1021 · Expanded synthetic participant 1021Site A — Urban Referral Hub
EXP-1022 · Expanded synthetic participant 1022Site A — Urban Referral Hub
EXP-1023 · Expanded synthetic participant 1023Site C — Rural Outreach Programme
EXP-1024 · Expanded synthetic participant 1024Site E — Resource-Constrained Navigation Programme
EXP-1025 · Expanded synthetic participant 1025Site E — Resource-Constrained Navigation Programme
EXP-1026 · Expanded synthetic participant 1026Site C — Rural Outreach Programme
EXP-1027 · Expanded synthetic participant 1027Site C — Rural Outreach Programme
EXP-1028 · Expanded synthetic participant 1028Site D — Community Engagement Programme
EXP-1029 · Expanded synthetic participant 1029Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1970
HPV DNA
3096
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.